Disruption of gender‐affirming health care, and COVID ‐19 illness, testing, and vaccination among trans Australians during the pandemic: a cross‐sectional survey
Medical Journal of Australia · 2024
DOI: 10.5694/mja2.52169 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Journal of Australia, 2024. Verfasst von Sav Zwickl und 7 weiteren Autor:innen. Beteiligte Einrichtung: The University of Melbourne, Melbourne, VIC. Hauptthemen laut MEDLINE: Australasian People, COVID-19, Vaccination, Gender-Affirming Care. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council.
Abstract (Originalsprache)
Objectives
To assess rates of disruption of gender‐affirming health care, of coronavirus disease 2019 (COVID‐19) illness, testing, and vaccination, and of discrimination in health care among Australian trans people during the COVID‐19 pandemic. Design, setting Online cross‐sectional survey (1–31 May 2022); respondents were participants recruited by snowball sampling for TRANSform, an Australian longitudinal survey‐based trans health study, 1 May – 30 June 2020.
Participants
People aged 16 years or older, currently living in Australia, and with a gender different to their sex recorded at birth. Main outcome measures Proportions of respondents who reported disruptions to gender‐affirming health care, COVID‐19 illness, testing, and vaccination, and positive and negative experiences during health care.
Results
Of 875 people invited, 516 provided valid survey responses (59%). Their median age was 33 years (interquartile range, 26–45 years); 193 identified as women or trans women (37%), 185 as men or trans men (36%), and 138 as non‐binary (27%). Of 448 respondents receiving gender‐affirming hormone therapy, 230 (49%) reported disruptions to treatment during the pandemic; booked gender‐affirming surgery had been cancelled or postponed for 37 of 85 respondents (44%). Trans‐related discrimination during health care was reported by a larger proportion of participants than in a pre‐pandemic survey (56% v 26%). COVID‐19 was reported by 132 respondents (26%), of whom 49 reported health consequences three months or more after the acute illness (37%; estimated Australian rate: 5–10%). Three or more COVID‐19 vaccine doses were reported by 448 participants (87%; Australian adult rate: 70%).
Conclusions
High rates of COVID‐19 vaccination among the trans people we surveyed may reflect the effectiveness of LGBTIQA+ community‐controlled organisation vaccination programs and targeted health promotion. Training health care professionals in inclusive services for trans people could improve access to appropriate health care and reduce discrimination.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The University of Melbourne, Melbourne, VIC.
- Austin Health, Melbourne, VIC.
- La Trobe University, Melbourne, VIC.
- ACON, Sydney, NSW.
ORCID-Profile: Ada S Cheung
Förderung
- National Health and Medical Research Council
Zitieren
APA
Zwickl, S., Ruggles, T., Wong, A. F., Ginger, A., Angus, L. M., Eshin, K., Cook, T., & Cheung, A. S. (2024). Disruption of gender‐affirming health care, and COVID ‐19 illness, testing, and vaccination among trans Australians during the pandemic: a cross‐sectional survey. Medical Journal of Australia. https://doi.org/10.5694/mja2.52169
Vancouver
Zwickl S, Ruggles T, Wong AF, Ginger A, Angus LM, Eshin K, et al. Disruption of gender‐affirming health care, and COVID ‐19 illness, testing, and vaccination among trans Australians during the pandemic: a cross‐sectional survey. Medical Journal of Australia. 2024. doi:10.5694/mja2.52169
BibTeX
@article{Zwickl2024,
author = {Zwickl, Sav and Ruggles, Tomi and Wong, Alex Fq and Ginger, Ariel and Angus, Lachlan M and Eshin, Kalen and Cook, Teddy and Cheung, Ada S},
title = {Disruption of gender‐affirming health care, and COVID ‐19 illness, testing, and vaccination among trans Australians during the pandemic: a cross‐sectional survey},
journal = {Medical Journal of Australia},
year = {2024},
doi = {10.5694/mja2.52169}
}
EUVIMED